Sökning: "renal development"
Visar resultat 11 - 15 av 221 avhandlingar innehållade orden renal development.
11. Late Effects After Autologous Bone Marrow Transplantation in Childhood
Sammanfattning : Fifty children with hematologic malignancies have been treated with autologous BMT in Uppsala. The aim was to describe late effects in this group with special reference to cataracts, reduced final height, and to hepatic, renal, and pulmonary late effects. LÄS MER
12. Diet and renal cell carcinoma
Sammanfattning : Renal cell carcinoma (RCC) represents 80-85% of all tumors of the kidney and is responsible for about 2% of all cancer deaths in developed countries. Its incidence varies among countries, among migrants, and by socioeconomic status suggesting that environmental factors play a major etiological role. LÄS MER
13. Epidemiological Aspects of Renal Impairment in Patients with Type 2 Diabetes
Sammanfattning : Diabetes is a leading cause of renal impairment (RI) and indication of the need for renal replacement therapy in many parts of the world. Albuminuria and RI are the two main forms of diabetic kidney disease. LÄS MER
14. Urinary tract infection in small children: aspects of bacteriology, vesicoureteral reflux and renal damage
Sammanfattning : Background: Urinary tract infection (UTI) is a prevalent bacterial infection in children. The diagnosis is based on growth of bacteria in urine specimen and treatment is chosen out of knowledge of the present antimicrobial resistance situation. Vesicoureteral reflux (VUR) is a well-known risk factor for UTI in children. LÄS MER
15. Development and application of new methods for anticancer drug discovery and early evaluation
Sammanfattning : A non-clonogenic assay using the redox dye Alamar Blue and primary human tumor cells (PHTC) from patients and human tumor cell lines (HTCL) was established for rapid screening and evaluation of anticancer drugs. PHTC cultures from chronic lymphocytic leukemia (CLL) and ovarian carcinoma (Ovca) were compared with renal carcinoma (ACHN) and lymphocytic (CCRF-CEM) HTLCs in response to 63 toxic or non-toxic compounds. LÄS MER